back to Australia directory
australia clinical guidance

Gout: acute flare + urate-lowering therapy (ULT)

A chapter-bounded Australian summary of gout: acute flare + urate-lowering therapy (ult), using exact named Queensland PCCM content and any exact national source listed on this page.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Queensland PCCM gout is a Queensland implementation source. Apply only the cited chapter scope and verify the equivalent state or territory pathway.

Scope

Acute gout recognition and first management under the exact Queensland PCCM adult gout chapter. Long-term urate-lowering initiation, titration and target selection are outside this chapter and require an exact separate source.
sources for this section:Queensland PCCM gout

The Bottom Line

  • Acute gout commonly causes rapid-onset severe pain, swelling and redness, often at the first metatarsophalangeal joint or knee.
  • Ask about previous attacks, trauma, fever, medicines, kidney disease and other causes of an acutely swollen joint.
  • Septic arthritis cannot be excluded solely because gout is plausible; systemic illness or diagnostic uncertainty requires urgent medical assessment.
  • Use the chapter and current local medicine policy for acute symptom treatment after checking kidney, gastrointestinal and cardiovascular risk.
sources for this section:Queensland PCCM gout

Practical clinical workflow

1
Record observations and examine the affected and other joints, skin, hydration and possible infection source.
2
Seek medical or nurse-practitioner advice when diagnosis is uncertain, illness is severe or medicine selection is complex.
3
Provide acute pain care within scope and explain that worsening fever or spreading inflammation requires prompt reassessment.
4
After the attack, arrange separate evidence-based review of recurrence, serum urate, comorbidity and whether long-term prevention is indicated.
sources for this section:Queensland PCCM gout

Safety boundaries and escalation

  • A hot swollen joint with fever, immunocompromise, prosthesis or systemic illness requires urgent septic-arthritis assessment.
  • This page makes no urate target, prophylaxis duration or long-term dose recommendation because those decisions are not covered by the cited PCCM chapter.
sources for this section:Queensland PCCM gout

Implementation

Queensland PCCM gout is a Queensland source. It supplies an Australian implementation example, not a national rule. Confirm the equivalent pathway, referral destination and medicine policy in the patient’s state or territory. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO–RACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:Queensland PCCM gout

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Queensland PCCM gout

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Queensland Health and Royal Flying Doctor Service Queensland SectionPrimary Clinical Care Manual, 12th edition: Gout — adultISBN 978-1-876560-22-5; Gout — adult, pp. 321–322 · 12th edition 2025, v1.03 with updates through 21 July 2026; exact chapter at printed pages 321–322 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.